路易斯安那 的 急性髓系白血病 臨床試驗
13 項針對 急性髓系白血病 的研究正在 路易斯安那 各地點尋找參與者。
路易斯安那 的城市
官方研究文本（英文）
Comparing Different Treatment Lengths for Venetoclax in Older People With Newly Diagnosed Acute Myeloid Leukemia (A MyeloMATCH Treatment Trial)
- LSU Health Baton Rouge-North Clinic, Baton Rouge
- Our Lady of the Lake Physician Group, Baton Rouge
招募中2 期
60 歲及以上 · 所有性別 · 更新於 2026年10月5日 · NCT07437950MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
- LSU Health Baton Rouge-North Clinic, Baton Rouge
- Our Lady of the Lake Physician Group, Baton Rouge
- Our Lady of The Lake, Baton Rouge
招募中2 期
18 歲及以上 · 所有性別 · 更新於 2026年10月5日 · NCT05564390Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- LSU Health Baton Rouge-North Clinic, Baton Rouge
- Our Lady of the Lake Physician Group, Baton Rouge
- Our Lady of The Lake, Baton Rouge
- 還有 7 項
招募中觀察性研究歡迎健康志工
40 至 75 歲 · 所有性別 · 更新於 2026年10月2日 · NCT05334069Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)
- LSU Health Baton Rouge-North Clinic, Baton Rouge
- Our Lady of the Lake Physician Group, Baton Rouge
- Our Lady of The Lake, Baton Rouge
招募中2 期
18 至 59 歲 · 所有性別 · 更新於 2026年9月28日 · NCT05554393Study of Revumenib in Combination With Intensive Chemotherapy in Newly Diagnosed Acute Myeloid Leukemia (AML) With a NPM1 Mutation
- Clinical Trial Site, Shreveport
招募中3 期
12 歲及以上 · 所有性別 · 更新於 2026年9月25日 · NCT07211958A Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants With Newly Diagnosed Acute Myeloid Leukemia (AML)
- Mary Bird Perkins Cancer Center, Baton Rouge
招募中3 期
18 歲及以上 · 所有性別 · 更新於 2026年9月25日 · NCT06852222Comparing New Treatments for People With Newly Diagnosed Acute Myeloid Leukemia That Has an IDH2 Gene Change (A MyeloMATCH Treatment Trial)
- LSU Health Baton Rouge-North Clinic, Baton Rouge
- Our Lady of the Lake Physician Group, Baton Rouge
- Our Lady of The Lake, Baton Rouge
招募中2 期
18 歲及以上 · 所有性別 · 更新於 2026年9月22日 · NCT06672146Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)
- LSU Health Baton Rouge-North Clinic, Baton Rouge
- Our Lady of the Lake Physician Group, Baton Rouge
- Our Lady of The Lake, Baton Rouge
招募中2 期
18 至 59 歲 · 所有性別 · 更新於 2026年9月22日 · NCT05554406Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)
- LSU Health Baton Rouge-North Clinic, Baton Rouge
- Our Lady of the Lake Physician Group, Baton Rouge
- Our Lady of The Lake, Baton Rouge
招募中2 期
18 歲及以上 · 所有性別 · 更新於 2026年9月22日 · NCT06317649A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations
- Children's Hospital New Orleans, New Orleans
- Ochsner Medical Center Jefferson, New Orleans
招募中3 期
6 Months – 21 Years · 所有性別 · 更新於 2026年9月17日 · NCT04293562The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
- Ochsner Medical Center Jefferson, New Orleans
招募中1/2 期
22 歲以下 · 所有性別 · 更新於 2026年8月25日 · NCT04726241A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
- Children's Hospital of New Orleans/LSUHSC, New Orleans
招募中觀察性研究
所有年齡 · 所有性別 · 更新於 2026年7月6日 · NCT01351545A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML
- Ochsner MD Anderson Cancer Center, Jefferson
招募中1 期
18 歲及以上 · 所有性別 · 更新於 2026年3月13日 · NCT05735184資料來源：ClinicalTrials.gov，擷取日期 2026年10月6日。各研究自行設定資格標準；由研究團隊決定參與者資格。